The Group established a subsidiary in the PRC to expand the development of the distribution of Chinese patent medicines and healthcare product businesses. Its experience and networks in the “Internet Plus” supply chain business will lay a sound foundation for distributing Chinese patent medicines and healthcare products and speed up the development of the delivery and supply chain services across regions in the country. As the healthcare industry chain is the Group’s key focus area of development, cooperating with various product brands will effectively accelerate the development and momentum of related businesses. On the other hand, the Group has also continued to expand the business related to the service agreement with platform operators in Mainland China. Through the platform operator’s different platforms, the Group provides one-stop product supply chain services.
The market demand for personal protective equipment decreased due to the receding impact of the pandemic and the resumption of social activities. Accordingly, the Group has reallocated its resources to exit from the development of personal protective equipment business and at the same time increase its investment in the supply chain services for the healthcare industry.